Science Explorer Back to mapMap
Discussion
Researcher · University Hospital of Basel · Switzerland

Thomas Menter

Thomas Menter publishes mostly in Pathology and Forensic Medicine, Oncology and Immunology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Viral-associated cancers and disorders.

ORCID 0000-0002-0847-6156 OpenAlex
World rank
#1,745,269
of 7,710,434 ranked researchers
Rank in Switzerland
#28,322
of 80,918
Works
145
Citations
3.9k
Citations per work
27.1
h-index
29
i10-index 56Top 14% in Pathology and Forensic Medicine
Thomas Menter

What does Thomas Menter research?

Thomas Menter's work is mostly in Medicine (44%), Immunology and Microbiology (9%).

Everything else: 69 works · 47.5% of their workHealth Sciences: 64 works · 43.8% of their workMedicine: 64 works · 43.8% of their workPathology and Forensic Medicine: 18 works · 12.6% of their workOncology: 16 works · 10.9% of their workInfectious Diseases: 12 works · 8.2% of their workGenetics: 9 works · 6.2% of their workHematology: 9 works · 5.9% of their workLife Sciences: 13 works · 8.7% of their workImmunology and Microbiology: 13 works · 8.7% of their workImmunology: 13 works · 8.7% of their workTHEIR WORKThomas Menter145works
Life Sciences9%Health Sciences44%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else6947.5%
    1. Medicine6443.8%
    1. Immunology and Microbiology138.7%
  1. 1Pathology and Forensic Medicine13% of their works
  2. 2Oncology11% of their works
  3. 3Immunology9% of their works
  4. 4Infectious Diseases8% of their works
  5. 5Genetics6% of their works
  6. 6Hematology6% of their works

Research topics

Which keywords describe Thomas Menter's research?

The keywords of their largest research topics: Rituximab, Classification, Lymphoma, Chronic Lymphocytic Leukemia, Genomic Aberrations, Epstein-Barr Virus, Kaposi's Sarcoma and Natural Killer Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Rituximab632 topics
  2. Classification431 topic
  3. Lymphoma431 topic
  4. Chronic Lymphocytic Leukemia201 topic
  5. Genomic Aberrations201 topic
  6. Epstein-Barr Virus161 topic
  7. Kaposi's Sarcoma161 topic
  8. NK Cell Recognition131 topic
  9. Natural Killer Cells131 topic
  10. Clinical Characteristics121 topic
  11. SARS-CoV-2121 topic
  12. Fetal Hydrops101 topic
  13. Glomerular Diseases101 topic
  14. Nephrotic Syndrome101 topic
  15. Parvovirus B19101 topic
  16. Kidney Transplantation91 topic
  17. Renal Allograft91 topic

Where does Thomas Menter work?

Thomas Menter's main affiliation in the publication record is University Hospital of Basel, Switzerland.

How many publications and citations does Thomas Menter have?

OpenAlex counts 145 works and 3,923 citations for Thomas Menter, an h-index of 29, ranking #1,745,269 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Thomas Menter. Posts are plain text and can be reported.